1351 related articles for article (PubMed ID: 26171115)
1. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
[TBL] [Abstract][Full Text] [Related]
2. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
Bhatia V; Sharma S
J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
4. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
Gugliandolo A; Bramanti P; Mazzon E
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
[TBL] [Abstract][Full Text] [Related]
5. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
Wang P; Wang ZY
Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
[TBL] [Abstract][Full Text] [Related]
6. Role of tau protein in Alzheimer's disease: The prime pathological player.
Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
8. The Implications of Autophagy in Alzheimer's Disease.
Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
10. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
Huang HC; Jiang ZF
J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
[TBL] [Abstract][Full Text] [Related]
11. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
12. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
13. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's pathogenesis and its link to the mitochondrion.
Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
[TBL] [Abstract][Full Text] [Related]
16. Pathological Changes of Tau Related to Alzheimer's Disease.
Chu D; Liu F
ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of natural products against Alzheimer's disease via autophagic removal of Aβ.
Hu M; Ying X; Zheng M; Wang C; Li Q; Gu L; Zhang X
Brain Res Bull; 2024 Jan; 206():110835. PubMed ID: 38043648
[TBL] [Abstract][Full Text] [Related]
18. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
Rai SN; Singh C; Singh A; Singh MP; Singh BK
Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
[TBL] [Abstract][Full Text] [Related]
20. Tauopathy: A common mechanism for neurodegeneration and brain aging.
Saha P; Sen N
Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
